Inhaled Glucocorticoid Flops for Speeding COVID Recovery in Outpatients
Inhaled fluticasone furoate failed to shorten recovery time for non-hospitalized adults with COVID-19, new data from the adaptive ACTIV-6 trial found. When used daily for 2 weeks, a quicker COVID-19 recovery time — considered at least 3 consecutive days without symptoms — was no more likely with fluticasone furoate than with placebo (HR 1.01, 95% […]
Asthma Drug Fluticasone Fails as Potential COVID Treatment
Latest Coronavirus News THURSDAY, July 14, 2022 (HealthDay News) The asthma drug fluticasone furoate is yet another medication that doesn’t work for mild-to-moderate COVID-19, a new study finds. “There was no evidence of improvement in time to recovery or reduction in hospitalizations in participants who took fluticasone furoate versus those who took a placebo,” lead […]